¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20
±³À°ÀÏÀÚ : 2019-04-20
±³À°Àå¼Ò : º¤½ºÄÚ 104È£ ¿Ü  
±³À°ÁÖÁ¦ : 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258  
À̸ÞÀÏ : herz8@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ 100,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 70,000¿ø ´çÀϵî·Ï: ±³¼ö ¹× °³¿øÀÇ 120,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 90,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-20 104È£ 09:00~09:12 Vascular Access for Coronary Intervention - TFI, TRI, Distal Radial  ÀÌÁØ¿ø(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:12~09:24 Vascular Access for Non-Coronary Intervention - TFI, TRI, Brachial, Others  °íÃæ¿ø(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:24~09:36 Hemostasis: A to Z  ÇãÁ¤È£(°í½ÅÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:36~09:48 How to Solve Access Site Problems  À¯»ó¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:48~10:00 Tips & Tricks of Vascular Access  ÀÌÀçȯ(Ãæ³²ÀÇ´ë) 
Åä·Ð 04-20 104È£ 10:00~10:30 Discussion  () 
È޽Ġ04-20  10:30~10:40 Break  () 
±³À°½Ã°£ 04-20 203È£ 10:40~10:55 Role of Myocardial Strain Imaging in Acyanotic CHD  ¿ÀÁøÈñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 10:55~11:10 Funtional Assessment Before and after VAD in Children with CHD  Á¤¼¼¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 11:10~11:25 How to Manage the Patients with Pulmonary Venous Obstruction in TAPVR : Pre-op & Post-op  ÀÌ»óÀ±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 11:25~11:55 Integrated Imaging Approach to Pulmonary Venous Obstruction  Shi-Joon Yoo(Univ. of Toronto Canada) 
Åä·Ð 04-20 203È£ 11:55~12:10 Discussion  () 
È޽Ġ04-20  12:10~12:15 Break  () 
±³À°½Ã°£ 04-20 201È£ 12:15~12:55 PIONEER-HF: Prime Time for ARNI in Stabilized AHF Patients  Eric Velazquez(Yale University USA) 
È޽Ġ04-20  12:55~13:10 Break  () 
±³À°½Ã°£ 04-20 205È£ 13:10~13:18 Pacing Maneuvers for SVT Differentiation  ±è¼ºÈ¯(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:18~13:26 Treatment of PSVT  ±èÁ¾À±(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:26~13:34 How I Overcame a Challenging Case of PSVT?  ¿À¼¼ÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:34~13:42 EKG localization: outflow VT  ÁøÀº¼±(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:42~13:50 EKG localization: non-outflow VT  ¿Â¿µ±Ù(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:50~13:58 Pharmacologic treatment of VT  ±èÀ¯¸®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:58~14:06 Neuromodulation in refractory ventricular arrhythmia  ¹Ú°æ¹Î(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 14:06~14:14 New Technique and Technologies in VT Ablation  ±èÁØ(¿ï»êÀÇ´ë) 
Åä·Ð 04-20 205È£ 14:14~14:40 Discussion  () 
È޽Ġ04-20  14:40~14:50 Break  () 
±³À°½Ã°£ 04-20 103È£ 14:50~15:10 What Is the Best Prognosticator in HF?: Imaging vs. Biomarker  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:10~15:30 Cardiac Cath Will Guide the Course and Management for HF  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:30~15:50 Imaging in Athletes: How to Differentiate with Pathology?  ¼±º´ÁÖ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:50~16:10 How to Use Cardiac Imaging for Therapeutic Guideline in HF  ¾çµ¿Çå(°æºÏÀÇ´ë) 
Åä·Ð 04-20 103È£ 16:10~16:20 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø 2019³â Á¦19ȸ ´ëÇÑÀü¸³¼±·¹ÀÌÀú¿¬±¸ÇÐȸ ÁýÁß½ÉÆ÷Áö¿ò : 2019-04-20
´ÙÀ½±Û ´ëÇѾȽŰæÀÇÇÐȸ 2019³â Ãá°èÇмú´ëȸ (Neurology of eye movements) : 2019-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
423 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 12ȸ °¡Å縯¼ºÇü½ÉÆ÷Áö¾ö : 2018-09-09 0 785 2018-08-15
422 ¼­¿ï Á߾Ӵ뺴¿ø È£Èí±â¾Ë·¹¸£±â³»°ú ¿¬¼ö°­Á : 2018-09-09 1 753 2018-08-15
421 ¼­¿ï ´ëÇѼºÇü¿Ü°úÇÐȸ Ç׳ëÈ­¼ºÇü¿¬±¸È¸ Á¦4ȸ ½ÉÆ÷Áö¾ö : 2018-09-09 0 803 2018-08-15
420 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦1ȸ ºñ¸¸Àü¹®°¡ ½ÉÈ­°úÁ¤: ºñ¸¸ Àü¹® ÀÎÁ¤ÀÇ ±³À° Part 1. : 2018-09-09 0 579 2018-08-15
419 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 2018³â Çù·Âº´ÀÇ¿ø ÀÇ»ç ¿¬¼ö°­Á : 2018-09-09 0 1,357 2018-08-15
418 ¼­¿ï Á¦1ȸ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ESD¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-09-08 0 868 2018-08-15
417 ¼­¿ï Á¦11ȸ ¼º±Õ°üÀÇ´ë »ï¼º¼­¿ïº´¿ø ÁßȯÀÚÀÇÇÐ ¿¬¼ö°­Á Basic Concepts in Intensive Care, 2018 (BACIC 2018) : 2018-09-08 0 1,377 2018-08-15
416 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ °í·Á´ëÇб³ °í°üÀý ½ÉÆ÷Áö¿ò : 2018-09-08 0 1,104 2018-08-15
415 ¼­¿ï 2018 ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ ¿öÅ©¼¥ : 2018-09-08 0 515 2018-08-15
414 ºÎ»ê ´ëÇѼ¼Æ÷º´¸®ÇÐȸ International Session of the 30th Annual Fall Meeting of the Korean Society for Cytopathology : 2018-09-08 0 590 2018-08-15
413 ºÎ»ê 2018³â ºÎ¿ï°æ³»ºÐºñ´ë»çÇÐȸ ´ç´¢º´±³À°ÀÚ ¼¼¹Ì³ª : 2018-09-08 0 1,040 2018-08-15
412 ±¤ÁÖ Àü³²´ëº´¿ø Á¦ 3Â÷ Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ°úÇб³½Ç ¿¬¼ö°­Á : 2018-09-08 0 1,091 2018-08-15
411 ºÎ»ê ºÎ»ê´ëº´¿ø 2018³â Á¦1Â÷ ¸ð¹ß¿¬¼ö±³À° (ÁÖÁ¦: Å»¸ðÁõÀÇ Áø´Ü°ú Ä¡·á) : 2018-09-08 0 1,432 2018-08-15
410 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¦6ȸ ¾ÆÁÖ ´ç´¢¹ß ¹× â»ó ½ÉÆ÷Áö¾ö : 2018-09-08 0 1,212 2018-08-15
409 ±¤ÁÖ 2018 Àü³²´ëÇб³º´¿ø ÁßȯÀÚÀÇÇнÉÆ÷Áö¿ò ¹× ±â°èȯ±â¿öÅ©¼ó : 2018-09-08 0 739 2018-08-15
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷